Teriparatide
PTH 1-34 / Forteo
- Peptide length
- 34 amino acids
Recombinant PTH (1–34)
Open the sources to check how the studies were done and what they can support.
The N-terminal fragment of parathyroid hormone, with randomized fracture-prevention evidence in osteoporosis.
- Family
- Parathyroid hormone fragment
- Research target
- PTH type 1 receptor
- Molecular form
- Recombinant PTH (1–34)
What to know about the research
Fracture outcomes, bone-density changes and biochemical markers answer different questions. Use the current product label for eligibility and duration restrictions.
Check the exact compound
Teriparatide is PTH (1–34), not full-length PTH and not the PTHrP-derived analog abaloparatide.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries